Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.
Launched by WROCLAW MEDICAL UNIVERSITY · Feb 6, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether giving vaccinations against respiratory illnesses, specifically Respiratory Syncytial Virus (RSV) and influenza, together can help improve the health of patients with chronic heart failure. The main goal is to see if these coordinated vaccinations can lead to better outcomes for these patients. The study is currently looking for participants aged 18 and older who have been diagnosed with heart failure and have not received these vaccinations before.
If you join the trial, you will receive the RSV and influenza vaccines as part of your care. It's important to note that you cannot participate if you have had a severe allergic reaction to vaccines in the past, are currently pregnant, or have an active infection. This study aims to provide valuable information about how vaccines might help improve the health and well-being of people with heart failure, so your participation could contribute to important findings in this area.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age above 18 years
- • Willingness to provide informed consent for participation in the study
- • Diagnosis of heart failure
- • No previous vaccination against RSV or influenza
- Exclusion Criteria:
- • History of an anaphylactic reaction to vaccination
- • Hypersensitivity to any component of the vaccine
- • Receipt of vaccination against RSV or influenza in the current infectious
- • Active infection
- • Pregnancy
About Wroclaw Medical University
Wrocław Medical University is a prestigious academic institution located in Wrocław, Poland, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in healthcare and biomedical sciences to facilitate innovative research initiatives aimed at improving patient outcomes. With a strong emphasis on ethical practices and regulatory compliance, Wrocław Medical University collaborates with a diverse network of healthcare professionals and researchers to conduct rigorous clinical trials that contribute to the development of new therapies and enhance the understanding of various medical conditions. Its dedication to scientific excellence and patient safety positions the university as a key player in the global clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wroclaw, Dolnyslask, Poland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported